Pharmaceutical Contract Development & Manufacturing Advisory


It’s all about VALUE

Strive not to be a success, but rather to be of VALUE.

Albert Einstein


Since more than decades we gained expertise in the following areas that will be beneficial to our clients.

  • Growth: organic and in-organic; including 12 acquisitions, divestitures and joint ventures

  • Value: increased top and bottom line, multiple turn abounds of CDMO businesses

  • Deals: numerous commercial supply agreements structured and negotiated; developed short and long term solutions for small to very large volumes and complexity

  • Organizations: built leadership teams, transformed cultures and Post Merger Integration

  • Global: extensive expertise to work with US, EU and Asian companies

  • Start Ups: mentoring, strategic positioning and business plans





Detlef Rethage

Mr. Rethage has served from 2005 to July 2018 as President of Nitto Avecia Inc, a leading Boston-based drug development services company for oligonucleotide based therapeutics. At Avecia, he spearheaded a successful turnaround and divestiture from Private Equity firms Cinven / Invest Corp to Nitto Denko.

Prior to Avecia, Mr. Rethage was the Executive Vice President Operations at Ricerca Biosciences, a drug discovery and development services company backed by SG Capital Partners.

From 1998 to 2002, Mr Rethage worked in for Degussa Corp. (today Evonik) as Vice President and General Manager of the Fine Chemicals Business based in New Jersey.  During that tenure, Mr. Rethage was also responsible for merging and integrating four businesses units into Fine Chemicals Division.

Earlier in his career, Mr. Rethage held positions in the Specialty Chemical Industry in Germany and Italy in Business Development, M&A and Corporate Development



MS Engineering, University Essen, Germany

MBA (equivalent) University Bochum, Germany


Other relevant Affiliations

  • Advisor to Brightwood Capital Advisors, LLC

  • Member Launchpad Venture Group

  • Mentor and Judge at Mass Challenge start-up accelerator